• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

匹莫林相关的肝损伤。

Pemoline-associated hepatic injury.

作者信息

Nehra A, Mullick F, Ishak K G, Zimmerman H J

机构信息

Veterans Administration Medical Center, Washington, D.C.

出版信息

Gastroenterology. 1990 Nov;99(5):1517-9. doi: 10.1016/0016-5085(90)91186-a.

DOI:10.1016/0016-5085(90)91186-a
PMID:2210262
Abstract

Among 100 cases of hepatic injury attributed to the administration of pemoline, 43 had sufficient accompanying information to permit analysis. All but two patients were less than 20 years old, and 80% were less than 12 years old. Males predominated the study. Injury appeared as early as 1 week or as late as greater than 1 year of taking the drug. The injury was uniformly hepatocellular as judged by the high values for aminotransferases and by death in massive necrosis in one patient. Mechanism was judged to be idiosyncratic, and the idiosyncrasy was probably metabolic rather than immunologic.

摘要

在100例因服用匹莫林导致肝损伤的病例中,43例有足够的伴随信息可供分析。除两名患者外,所有患者年龄均小于20岁,80%的患者年龄小于12岁。研究以男性为主。损伤最早出现在服药1周后,最晚出现在服药1年多后。根据转氨酶的高值以及1例患者因大块坏死死亡判断,损伤均为肝细胞性。其机制被判定为特异质性,且这种特异质性可能是代谢性的而非免疫性的。

相似文献

1
Pemoline-associated hepatic injury.匹莫林相关的肝损伤。
Gastroenterology. 1990 Nov;99(5):1517-9. doi: 10.1016/0016-5085(90)91186-a.
2
Pemoline (Cylert)-induced hepatotoxicity.匹莫林(赛乐特)所致肝毒性。
J Pediatr Gastroenterol Nutr. 1990 Jul;11(1):143-4. doi: 10.1097/00005176-199007000-00031.
3
Pemoline hepatotoxicity in children.儿童匹莫林的肝毒性。
J Pediatr. 1998 May;132(5):894-7. doi: 10.1016/s0022-3476(98)70329-4.
4
Hepatotoxicity due to pemoline. Report of two cases.匹莫林所致肝毒性。两例报告。
Digestion. 1973;9(6):532-9. doi: 10.1159/000197482.
5
Hepatotoxicity due to pemoline (Cylert): a report of two cases.匹莫林(赛乐特)所致肝毒性:两例报告。
J Pediatr Gastroenterol Nutr. 1990 Feb;10(2):239-41. doi: 10.1097/00005176-199002000-00016.
6
Pemoline hepatotoxicity and postmarketing surveillance.匹莫林的肝毒性及上市后监测。
J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):622-9. doi: 10.1097/00004583-200106000-00006.
7
Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis.4例与匹莫林相关的严重肝毒性:可能的自身免疫发病机制。
Pediatrics. 1998 May;101(5):921-3. doi: 10.1542/peds.101.5.921.
8
Pemoline-induced chorea.
Neurology. 1981 Mar;31(3):356-60. doi: 10.1212/wnl.31.3.256.
9
Hepatitis associated with pemoline.匹莫林相关肝炎
South Med J. 1984 Jul;77(7):938. doi: 10.1097/00007611-198407000-00043.
10
Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases.酮康唑治疗相关的肝损伤。33例病例分析。
Gastroenterology. 1984 Mar;86(3):503-13.

引用本文的文献

1
Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective.中枢兴奋剂治疗儿童注意缺陷多动障碍:来自美国的观点、问题和建议。
CNS Drugs. 1997 Apr;7(4):264-72. doi: 10.2165/00023210-199707040-00002.
2
A surveillance method for the early identification of idiosyncratic adverse drug reactions.一种用于早期识别特异质性药物不良反应的监测方法。
Drug Saf. 2008;31(2):169-80. doi: 10.2165/00002018-200831020-00006.
3
Clinical pharmacokinetics of atomoxetine.托莫西汀的临床药代动力学
Clin Pharmacokinet. 2005;44(6):571-90. doi: 10.2165/00003088-200544060-00002.
4
European clinical guidelines for hyperkinetic disorder -- first upgrade.欧洲多动障碍临床指南——首次更新。
Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I7-30. doi: 10.1007/s00787-004-1002-x.
5
Benefits and risks of pharmacotherapy for narcolepsy.发作性睡病药物治疗的益处与风险。
Drug Saf. 2002;25(11):791-809. doi: 10.2165/00002018-200225110-00004.
6
Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.注意缺陷多动障碍治疗中的药代动力学和药效学药物相互作用。
Clin Pharmacokinet. 2001;40(10):753-72. doi: 10.2165/00003088-200140100-00004.
7
Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner.儿童和青少年精神疾病的药物治疗:关注初级保健从业者指南
Drugs. 1996 May;51(5):750-9. doi: 10.2165/00003495-199651050-00004.
8
Identifying patients at risk for, and treatment of major psychiatric complications of cancer.识别癌症主要精神并发症的高危患者及其治疗。
Support Care Cancer. 1995 Jan;3(1):45-60. doi: 10.1007/BF00343921.